Quest Diagnostics Incorporated (0KSX.L)
USD 152.97
(-2.05%)
USD 152.97
(-2.05%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.68 Billion USD | 8.73% |
| 2022 | 4.3 Billion USD | 13.79% |
| 2021 | 3.78 Billion USD | 8.24% |
| 2020 | 3.49 Billion USD | -15.45% |
| 2019 | 4.13 Billion USD | 10.06% |
| 2018 | 3.75 Billion USD | 3.04% |
| 2017 | 3.64 Billion USD | 8.06% |
| 2016 | 3.37 Billion USD | -4.06% |
| 2015 | 3.51 Billion USD | -1.46% |
| 2014 | 3.57 Billion USD | 13.51% |
| 2013 | 3.14 Billion USD | 2.51% |
| 2012 | 3.06 Billion USD | -20.52% |
| 2011 | 3.86 Billion USD | 51.91% |
| 2010 | 2.54 Billion USD | -1.25% |
| 2009 | 2.57 Billion USD | -9.06% |
| 2008 | 2.82 Billion USD | -16.12% |
| 2007 | 3.37 Billion USD | 139.86% |
| 2006 | 1.4 Billion USD | -6.25% |
| 2005 | 1.5 Billion USD | 46.28% |
| 2004 | 1.02 Billion USD | 8.21% |
| 2003 | 947.69 Million USD | 30.58% |
| 2002 | 725.76 Million USD | 3.77% |
| 2001 | 699.4 Million USD | -18.16% |
| 2000 | 854.63 Million USD | -28.15% |
| 1999 | 1.18 Billion USD | 354.18% |
| 1998 | 261.9 Million USD | -25.83% |
| 1997 | 353.1 Million USD | -28.5% |
| 1996 | 493.83 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.81 Billion USD | -1.25% |
| 2024 Q1 | 4.87 Billion USD | 4.16% |
| 2024 Q3 | 5.48 Billion USD | 28.84% |
| 2023 Q3 | 4.76 Billion USD | -1.32% |
| 2023 Q2 | 4.83 Billion USD | 8.68% |
| 2023 FY | 4.68 Billion USD | 8.73% |
| 2023 Q4 | 4.68 Billion USD | -1.8% |
| 2023 Q1 | 4.44 Billion USD | 3.25% |
| 2022 FY | 4.3 Billion USD | 13.79% |
| 2022 Q3 | 3.94 Billion USD | 2.42% |
| 2022 Q4 | 4.3 Billion USD | 9.31% |
| 2022 Q1 | 3.95 Billion USD | 4.39% |
| 2022 Q2 | 3.84 Billion USD | -2.63% |
| 2021 Q4 | 3.78 Billion USD | 3.33% |
| 2021 Q3 | 3.66 Billion USD | -10.37% |
| 2021 FY | 3.78 Billion USD | 8.24% |
| 2021 Q1 | 3.43 Billion USD | -1.89% |
| 2021 Q2 | 4.08 Billion USD | 19.12% |
| 2020 Q2 | 4.14 Billion USD | -2.33% |
| 2020 Q3 | 3.54 Billion USD | -14.58% |
| 2020 FY | 3.49 Billion USD | -15.45% |
| 2020 Q1 | 4.24 Billion USD | 2.71% |
| 2020 Q4 | 3.49 Billion USD | -1.33% |
| 2019 Q4 | 4.13 Billion USD | 0.61% |
| 2019 FY | 4.13 Billion USD | 10.06% |
| 2019 Q1 | 4.31 Billion USD | 14.77% |
| 2019 Q2 | 4.26 Billion USD | -1.18% |
| 2019 Q3 | 4.11 Billion USD | -3.54% |
| 2018 Q3 | 3.43 Billion USD | -4.08% |
| 2018 FY | 3.75 Billion USD | 3.04% |
| 2018 Q4 | 3.75 Billion USD | 9.4% |
| 2018 Q2 | 3.58 Billion USD | -4.12% |
| 2018 Q1 | 3.73 Billion USD | 2.41% |
| 2017 FY | 3.64 Billion USD | 8.06% |
| 2017 Q2 | 3.42 Billion USD | 1.75% |
| 2017 Q1 | 3.36 Billion USD | -0.33% |
| 2017 Q4 | 3.64 Billion USD | 6.82% |
| 2017 Q3 | 3.41 Billion USD | -0.26% |
| 2016 FY | 3.37 Billion USD | -4.06% |
| 2016 Q1 | 3.77 Billion USD | 7.16% |
| 2016 Q2 | 3.55 Billion USD | -5.6% |
| 2016 Q3 | 3.41 Billion USD | -4.02% |
| 2016 Q4 | 3.37 Billion USD | -1.2% |
| 2015 Q1 | 3.75 Billion USD | 5.24% |
| 2015 Q3 | 3.6 Billion USD | 0.61% |
| 2015 Q4 | 3.51 Billion USD | -2.49% |
| 2015 FY | 3.51 Billion USD | -1.46% |
| 2015 Q2 | 3.58 Billion USD | -4.55% |
| 2014 Q3 | 3.69 Billion USD | -3.15% |
| 2014 FY | 3.57 Billion USD | 13.51% |
| 2014 Q1 | 3.8 Billion USD | 20.92% |
| 2014 Q2 | 3.81 Billion USD | 0.29% |
| 2014 Q4 | 3.57 Billion USD | -3.36% |
| 2013 Q2 | 3.34 Billion USD | 2.46% |
| 2013 Q4 | 3.14 Billion USD | -1.98% |
| 2013 Q3 | 3.2 Billion USD | -4.17% |
| 2013 Q1 | 3.26 Billion USD | 6.51% |
| 2013 FY | 3.14 Billion USD | 2.51% |
| 2012 FY | 3.06 Billion USD | -20.52% |
| 2012 Q1 | 3.77 Billion USD | -2.22% |
| 2012 Q2 | 3.64 Billion USD | -3.32% |
| 2012 Q3 | 3.33 Billion USD | -8.51% |
| 2012 Q4 | 3.06 Billion USD | -8.1% |
| 2011 Q3 | 4.09 Billion USD | -1.22% |
| 2011 Q1 | 3.22 Billion USD | 27.11% |
| 2011 FY | 3.86 Billion USD | 51.91% |
| 2011 Q4 | 3.86 Billion USD | -5.69% |
| 2011 Q2 | 4.14 Billion USD | 28.29% |
| 2010 Q1 | 2.65 Billion USD | 3.07% |
| 2010 FY | 2.54 Billion USD | -1.25% |
| 2010 Q3 | 2.79 Billion USD | 3.75% |
| 2010 Q4 | 2.54 Billion USD | -9.19% |
| 2010 Q2 | 2.69 Billion USD | 1.7% |
| 2009 FY | 2.57 Billion USD | -9.06% |
| 2009 Q1 | 2.87 Billion USD | 1.72% |
| 2009 Q2 | 2.96 Billion USD | 2.97% |
| 2009 Q3 | 2.73 Billion USD | -7.72% |
| 2009 Q4 | 2.57 Billion USD | -5.91% |
| 2008 Q1 | 3.25 Billion USD | -3.43% |
| 2008 FY | 2.82 Billion USD | -16.12% |
| 2008 Q4 | 2.82 Billion USD | -0.44% |
| 2008 Q2 | 3.11 Billion USD | -4.34% |
| 2008 Q3 | 2.84 Billion USD | -8.81% |
| 2007 FY | 3.37 Billion USD | 139.86% |
| 2007 Q1 | 1.84 Billion USD | 31.33% |
| 2007 Q3 | 3.59 Billion USD | -5.02% |
| 2007 Q4 | 3.37 Billion USD | -6.29% |
| 2007 Q2 | 3.78 Billion USD | 105.2% |
| 2006 Q2 | 1.38 Billion USD | 0.43% |
| 2006 Q3 | 1.45 Billion USD | 4.99% |
| 2006 Q4 | 1.4 Billion USD | -3.06% |
| 2006 Q1 | 1.37 Billion USD | -8.28% |
| 2006 FY | 1.4 Billion USD | -6.25% |
| 2005 Q3 | 644.21 Million USD | -0.91% |
| 2005 Q4 | 1.5 Billion USD | 132.86% |
| 2005 Q2 | 650.12 Million USD | -15.35% |
| 2005 Q1 | 768.03 Million USD | -25.11% |
| 2005 FY | 1.5 Billion USD | 46.28% |
| 2004 FY | 1.02 Billion USD | 8.21% |
| 2004 Q4 | 1.02 Billion USD | 13.83% |
| 2004 Q3 | 900.95 Million USD | -6.57% |
| 2004 Q2 | 964.32 Million USD | 5.71% |
| 2004 Q1 | 912.27 Million USD | -3.74% |
| 2003 FY | 947.69 Million USD | 30.58% |
| 2003 Q4 | 947.69 Million USD | -8.02% |
| 2003 Q3 | 1.03 Billion USD | -2.01% |
| 2003 Q2 | 1.05 Billion USD | -10.08% |
| 2003 Q1 | 1.16 Billion USD | 61.12% |
| 2002 Q4 | 725.76 Million USD | -22.3% |
| 2002 FY | 725.76 Million USD | 3.77% |
| 2002 Q3 | 934.02 Million USD | -9.56% |
| 2002 Q2 | 1.03 Billion USD | 53.64% |
| 2002 Q1 | 672.16 Million USD | -3.89% |
| 2001 Q3 | 719.65 Million USD | -14.35% |
| 2001 FY | 699.4 Million USD | -18.16% |
| 2001 Q4 | 699.4 Million USD | -2.81% |
| 2001 Q1 | 902.78 Million USD | 5.63% |
| 2001 Q2 | 840.25 Million USD | -6.93% |
| 2000 Q1 | 1.17 Billion USD | -1.04% |
| 2000 Q2 | 1.09 Billion USD | -6.98% |
| 2000 Q4 | 854.63 Million USD | -16.77% |
| 2000 FY | 854.63 Million USD | -28.15% |
| 2000 Q3 | 1.02 Billion USD | -6.23% |
| 1999 Q4 | 1.18 Billion USD | -3.32% |
| 1999 FY | 1.18 Billion USD | 354.18% |
| 1999 Q1 | 262.4 Million USD | 0.19% |
| 1999 Q2 | 251.4 Million USD | -4.19% |
| 1999 Q3 | 1.23 Billion USD | 389.42% |
| 1998 FY | 261.9 Million USD | -25.83% |
| 1998 Q4 | 261.9 Million USD | -9.56% |
| 1998 Q1 | 334.5 Million USD | -5.27% |
| 1998 Q3 | 289.6 Million USD | -13.89% |
| 1998 Q2 | 336.3 Million USD | 0.54% |
| 1997 Q4 | 353.1 Million USD | -9.67% |
| 1997 Q2 | 439.9 Million USD | -1.76% |
| 1997 Q1 | 447.8 Million USD | -9.35% |
| 1997 FY | 353.1 Million USD | -28.5% |
| 1997 Q3 | 390.9 Million USD | -11.14% |
| 1996 Q4 | 494 Million USD | -58.28% |
| 1996 Q3 | 1.18 Billion USD | 0.0% |
| 1996 FY | 493.83 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 6299.611% |
| Accuray Incorporated | 103.58 Million USD | -4420.881% |
| Align Technology, Inc. | -840.47 Million USD | 657.188% |
| Elevance Health Inc. | 18.59 Billion USD | 74.814% |
| AxoGen, Inc. | 32.26 Million USD | -14413.73% |
| Boston Scientific Corporation | 8.23 Billion USD | 43.112% |
| CVS Health Corporation | 71.18 Billion USD | 93.422% |
| Cardinal Health, Inc. | 476 Million USD | -883.824% |
| Centene Corporation | 506 Million USD | -825.494% |
| DaVita Inc. | 10.65 Billion USD | 56.036% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 88.557% |
| Hologic, Inc. | 374.4 Million USD | -1150.801% |
| Humana Inc. | 5.51 Billion USD | 15.148% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -848.076% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 13.556% |
| Masimo Corporation | 804 Million USD | -482.463% |
| McKesson Corporation | 889 Million USD | -426.772% |
| Patterson Companies, Inc. | 648.47 Million USD | -622.152% |
| ResMed Inc. | 635.57 Million USD | -636.814% |
| Henry Schein, Inc. | 2.57 Billion USD | -82.218% |
| Teladoc Health, Inc. | 468.6 Million USD | -899.356% |
| Universal Health Services, Inc. | 5.24 Billion USD | 10.752% |
| Veeva Systems Inc. | -647.71 Million USD | 823.007% |
| Baxter International Inc. | 11.16 Billion USD | 58.06% |
| Becton, Dickinson and Company | 14.46 Billion USD | 67.621% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 276.033% |
| Danaher Corporation | 13.49 Billion USD | 65.291% |
| Stryker Corporation | 10.02 Billion USD | 53.282% |
| Medtronic plc | 23.67 Billion USD | 80.223% |